Predictors of stroke in patients receiving chronic hemodialysis.

被引：0
|
作者：
Iseki, K
Fukiyama, K
机构：
[1] UNIV RYUKYUS, DIALYSIS UNIT, OKINAWA, JAPAN
[2] UNIV RYUKYUS, DEPT INTERNAL MED 3, OKINAWA, JAPAN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A1169 / A1169
页数：1
相关论文
共 50 条
  • [1] Predictors of stroke in patients receiving chronic hemodialysis
    Iseki, K
    Fukiyama, K
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (05) : 1672 - 1675
  • [2] Telavancin pharmacokinetics in patients with chronic kidney disease receiving hemodialysis.
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    [J]. PHARMACOTHERAPY, 2016, 36 (12): : E256 - E256
  • [3] Predictors of bone mineral density in patients on hemodialysis.
    El-Hajj Fuleihan, G
    Zayour, D
    Daouk, M
    Medawar, W
    Salamoun, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S488 - S488
  • [4] Dental findings in chronic renal failure patients receiving chronic ambulatory peritoneal dialysis and hemodialysis.
    Duran, I
    Erdemir, E
    Türk, S
    [J]. JOURNAL OF DENTAL RESEARCH, 2002, 81 : B357 - B357
  • [5] Predictors of morbidity in maintenance hemodialysis.
    Supasyndh, O
    Mehrotra, R
    Hurst, L
    Leonardi, M
    Bross, R
    Kopple, JD
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 627A - 627A
  • [6] Survival analysis of patients undergoing chronic hemodialysis.
    Kim, SS
    Kim, JS
    Kim, JH
    Hwang, PJ
    Na, GR
    Oh, SM
    Bin, KT
    Lee, KW
    Han, MH
    Lee, KS
    Sin, YT
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (05) : 1802 - 1802
  • [7] Tips for patients with refractory ascites and chronic hemodialysis.
    Ochs, A
    Rossle, M
    Haag, K
    Piotraschke, J
    Schollmeyer, P
    Blum, HE
    [J]. HEPATOLOGY, 1996, 24 (04) : 1275 - 1275
  • [8] Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
    Shinefield, H
    Black, S
    Fattom, A
    Horwith, G
    Rasgon, S
    Ordonez, J
    Yeoh, H
    Law, D
    Robbins, JB
    Schneerson, R
    Muenz, L
    Naso, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 491 - 496
  • [9] Nephrogenic fibrosing dermopathy is prevalent among patients receiving hemodialysis.
    Todd, DJ
    Kay, J
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S592 - S593
  • [10] Markers of apoptosis and cellular death in patients on chronic hemodialysis.
    Soubassi, LP
    Sarandakou, A
    Kotsis, B
    Chaniotis, DI
    Zerefos, SN
    Soubassi, SP
    Zerefos, NS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A31 - A31
12345